Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Colonic Neoplasms: full-pipeline trial registry
6 of 15 indexed Colonic Neoplasms trials are currently recruiting.
Corpus placement: #1,140 of 28,707 conditions by registered trial count.
15 US clinical trials · 6 currently recruiting · #1,140 of 28,707 conditions by registered trial count
Colonic Neoplasms: 15 US clinical trials tracked, 6 recruiting.
Colonic Neoplasms is the subject of 15 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is AdventHealth Translational Research Institute, running 2 of these trials.
Enrollment posture brief
Registry condition colonic-neoplasms
OPEN 6 | RECR 40% | LATE 2 | EARLY 3 | RANK #1140 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)
Colonic Neoplasms lists 6 open slots (40% of 15 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Colonic Neoplasms on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Colonic Neoplasms is recruiting below its size-band peers.
6 of 15 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Colonic Neoplasms trials is spread across many organizations.
AdventHealth Translational Research Institute accounts for 2 of 15 trials (13.3%). 13 distinct sponsors appear on at least one study for this condition label.
-
Typical Colonic Neoplasms enrolment sits around 284 participants.
Median target enrolment is 284 among the 15 trials that report a genuine target (sentinel values excluded). 4 of those (26.7%) plan for fewer than 100 participants.
-
Colonic Neoplasms research is mostly interventional.
13 interventional and 2 observational studies make up this index (86.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
15 total, page 1 of 1
Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas
University of Michigan Rogel Cancer Center
NCT00843375
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
GlaxoSmithKline
NCT05855200
Strategies for Optimizing a Mailed FIT Program in Appalachia
Ohio State University Comprehensive Cancer Center
NCT07173985
Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer
AdventHealth Translational Research Institute
NCT05773144
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
National Cancer Institute (NCI)
NCT06885697
Effects of Aerobic Exercise on Skeletal Muscle Remodeling in Colorectal Cancer
AdventHealth Translational Research Institute
NCT05789433
Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers
Memorial Sloan Kettering Cancer Center
NCT00579163
Mailed FIT Outreach to Improve Colon Cancer Screening in the Safety-net System
University of California, San Francisco
NCT02613260
Improving Bowel Preparation for Colonoscopy With a Simple Educational Card
Boston Medical Center
NCT00643682
Japanese National Computed Tomographic (CT) Colonography Trial
Japanese CT Colonography Society
NCT00997802
Clinical Evaluation of Narrow Band Imaging Colonoscope
VA Palo Alto Health Care System
NCT00628147
Trial of a Computer-Based Presentation of Quantitative Information About Colorectal Cancer Screening
Indiana University
NCT01415479
Effect of High-Legume Diet on Colorectal Cancer Risk
National Cancer Institute (NCI)
NCT00339469
Case Series With Saneso 3600 Colonoscope
Saneso
NCT05505370
An Open Label Study of a Peptide Vaccine in Patients With Stage III Colon Cancer
Epimmune
NCT00054912
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 3 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Colonic Neoplasms records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Colonic Neoplasms trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Colonic Neoplasms page
15 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 6 Colonic Neoplasms trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- AdventHealth Translational Research Institute sponsors the most Colonic Neoplasms trials on record, review their full trial history before evaluating a specific study. See AdventHealth Translational Research Institute's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Colonic Neoplasms condition card totals 15 registered trials; most-linked intervention Progressive stretching; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.